Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,794,743
-
Total 13F shares
-
10,285,308
-
Share change
-
+507,419
-
Total reported value
-
$77,138,000
-
Price per share
-
$7.50
-
Number of holders
-
42
-
Value change
-
+$3,821,299
-
Number of buys
-
29
-
Number of sells
-
8
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2018
As of 31 Mar 2018,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,285,308 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FMR LLC, SPHERA FUNDS MANAGEMENT LTD., 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, MANGROVE PARTNERS, Knoll Capital Management, LP, and Hikari Power Ltd.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.